Related Experiment Video
Updated: Aug 30, 2025

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
Published on: June 14, 2016
Home Dust Mites Promote MUC5AC Hyper-Expression by Modulating the sNASP/TRAF6 Axis in the Airway Epithelium
Ming-Zhen Chen1, Shao-An Wang1, Shih-Chang Hsu2,3
1School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Abstract:
House dust mites (HDMs) are a common source of respiratory allergens responsible for allergic asthma and innate immune responses in human diseases. Since HDMs are critical factors in the triggering of allergen-induced airway mucosa from allergic asthma, we aimed to investigate the mechanisms of Toll-like receptors (TLR) in the signaling of the HDM extract that is involved in mucus hypersecretion and airway inflammation through the engagement of innate immunity. Previously, we reported that the somatic nuclear autoantigenic sperm protein (sNASP)/tumor necrosis factor receptor-associated factor 6 (TRAF6) axis controls the initiation of TLRs to maintain the homeostasis of the innate immune response. The present study showed that the HDM extract stimulated the biogenesis of Mucin 5AC (MUC5AC) in bronchial epithelial cells via the TLR2/4 signaling pathway involving MyD88 and TRAF6. Specifically, sNASP binds to TRAF6 in unstimulated bronchial epithelial cells to prevent the activation of TRAF6-depenedent kinases. Upon on HDMs' stimulation, sNASP is phosphorylated, leading to the activation of TRAF6 downstream of the p38 MAPK and NF-κB signaling pathways. Further, NASP-knockdown enhanced TRAF6 signaling and MUC5AC biogenesis. In the HDM-induced mouse asthma model, we found that the HDM extract promoted airway hyperresponsiveness (AHR), MUC5AC, and allergen-specific IgE production as well as IL-5 and IL-13 for recruiting inflammatory cells. Treatment with the PEP-NASP peptide, a selective TRAF6-blocking peptide, ameliorated HDM-induced asthma in mice. In conclusion, this study indicated that the sNASP/TRAF6 axis plays a regulatory role in asthma by modulating mucus overproduction, and the PEP-NASP peptide might be a potential target for asthma treatment.
Insights
House dust mites trigger asthma by activating Toll-like receptors (TLR), leading to mucus overproduction. A new study reveals the somatic nuclear autoantigenic sperm protein (sNASP)/TRAF6 pathway regulates this response, offering a potential therapeutic target.
Area of Science:
- Immunology
- Molecular Biology
- Respiratory Medicine
Background:
- House dust mites (HDMs) are major respiratory allergens linked to allergic asthma.
- Innate immunity, particularly Toll-like receptors (TLRs), plays a crucial role in HDM-induced airway inflammation and mucus production.
Purpose of the Study:
- To investigate the signaling mechanisms of HDM extract in activating TLRs, leading to mucus hypersecretion and airway inflammation.
- To elucidate the role of the somatic nuclear autoantigenic sperm protein (sNASP)/tumor necrosis factor receptor-associated factor 6 (TRAF6) axis in HDM-induced asthma.
Main Methods:
- Investigated HDM extract's effect on Mucin 5AC (MUC5AC) biogenesis in bronchial epithelial cells via TLR2/4 signaling.
- Examined the interaction between sNASP and TRAF6, and downstream signaling pathways (p38 MAPK, NF-κB).
- Utilized a mouse model of HDM-induced asthma and tested a TRAF6-blocking peptide (PEP-NASP).
Main Results:
- HDM extract stimulated MUC5AC biogenesis through the TLR2/4/MyD88/TRAF6 pathway.
- sNASP normally inhibits TRAF6 activation; HDM stimulation phosphorylates sNASP, activating TRAF6 and downstream pathways.
- NASP-knockdown exacerbated TRAF6 signaling and MUC5AC production.
- HDM-induced asthma model showed increased airway hyperresponsiveness, MUC5AC, IgE, IL-5, and IL-13.
- PEP-NASP treatment ameliorated HDM-induced asthma symptoms in mice.
Conclusions:
- The sNASP/TRAF6 axis is a key regulator of HDM-induced mucus overproduction and airway inflammation in asthma.
- Targeting the sNASP/TRAF6 interaction with peptides like PEP-NASP shows therapeutic potential for allergic asthma treatment.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

